Delivery Order SPE2DB22D9316-SPE2DB24FYN26
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 milligram vials of the pharmaceutical drug Entyvio. The delivery order has a potential value of $14,786.04 and a completion date of February 6, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles with DLA to supply a wide range of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Entyvio 300 mg vials. The order is valued at $96,245.20 and has a performance period through January 17, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple contracts and indefinite delivery vehicles (IDVs) with DLA Troop Support Medical to supply a variety of pharmaceutical and medical products in support of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the pharmaceutical product Entyvio 300 mg vials, with a potential value of $111,200.16 and a completion date of November 15, 2021. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand name and generic prescription drugs and medical supplies to the federal...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the drug Entyvio. The delivery order, valued at $141,773.70, has a completion date of November 21, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles (IDVs) to supply pharmaceuticals and medical products to military treatment facilities...
- This is a $49,449.30 firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The order is for 300 mg vials of the drug Entyvio, with a completion date of June 12, 2025. DMS Pharmaceutical Group is an established federal contractor that holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA to provide a wide range of pharmaceutical products, including branded and generic prescription drugs,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of 300 mg Entyvio vials. The contract has a ceiling value of $92,666.80 and an ultimate completion date of October 5, 2021. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business organization. The $113,685.84 order is for the pharmaceutical product Entyvio 300 mg vials, with a completion date of February 15, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a variety of brand and generic prescription and over-the-counter drug supplies to the federal government,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the pharmaceutical product Entyvio 300 mg vials, with a potential value of $113,685.84 and a completion date of May 2, 2022. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the prescription drug Entyvio. The order has a completion date of January 20, 2022 and a potential value of $111,200.16. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles with the Defense Logistics Agency to supply a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $39,559.44 contract is for the delivery of 4,568,056,273 units of the medication Entyvio 300 mg vials. The contract has an ultimate completion date of May 14, 2025 and was awarded on April 23, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB24FYN26Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 300 mg vials of the drug Entyvio. The order, valued at $4,928.68, has a completion date of February 12, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and Indefinite Delivery Vehicles (IDVs) with DLA to supply a variety of pharmaceutical and medical products to support military treatment facilities worldwide. This delivery order is issued against one of DMS Pharmaceutical Group's existing IDVs with DLA, which has a potential value of up to $5 million and provides the necessary pharmaceutical items and medical supplies on a firm fixed price basis to fulfill the routine needs of military treatment centers supported by DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 1/22/24 |